PD-L1 Positive Cervical Cancer
Cervical cancer, driven predominantly by persistent human papillomavirus (HPV) infection, remains a leading cause of cancer-related mortality in women worldwide. The identification of Programmed Death-Ligand 1 (PD-L1) expression in cervical tumors has introduced a pivotal biomarker for patient selection in immune checkpoint therapy. PD-L1 positive cervical cancer represents a biologically distinct entity with unique immune